Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
Net Issuance of Common Stock
Samsung Biologics Co Ltd
Net Issuance of Common Stock Peer Comparison
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Samsung Biologics Co Ltd
KRX:207940
|
Net Issuance of Common Stock
₩80m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Net Issuance of Common Stock
-₩891.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Net Issuance of Common Stock
-₩1.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
C
|
Cellivery Therapeutics Inc
KOSDAQ:268600
|
Net Issuance of Common Stock
₩2.5B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
See Also
What is Samsung Biologics Co Ltd's Net Issuance of Common Stock?
Net Issuance of Common Stock
80m
KRW
Based on the financial report for Mar 31, 2024, Samsung Biologics Co Ltd's Net Issuance of Common Stock amounts to 80m KRW.
What is Samsung Biologics Co Ltd's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 1Y
-100%
Over the last year, the Net Issuance of Common Stock growth was -100%.